Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated May 30, 2023, titled "Sun Pharma Announces China NMPA Approval For ILUMETRI (Tildrakizumab Injection) For Treatment Of Adults with Moderate-To-Severe Plaque Psoriasis".